Cross-resistance between taxanes and new hormonal agents abiraterone and enzalutamide may affect drug sequence choices in metastatic castration-resistant prostate cancer
van Soest, R.J, van Royen, M.E, de Morrée, E.S, Moll, J.M, Teubel, W, Wiemer, E.A.C, Mathijssen, R.H.J, de Wit, R, van Weerden, W.M
Published in European journal of cancer (1990) (01.12.2013)
Published in European journal of cancer (1990) (01.12.2013)
Get full text
Journal Article
Disconnecting the yin and yang relation of epidermal growth factor receptor (EGFR)-mediated delivery: a fully synthetic, EGFR-targeted gene transfer system avoiding receptor activation
Schäfer, A, Pahnke, A, Schaffert, D, van Weerden, W M, de Ridder, C M A, Rödl, W, Vetter, A, Spitzweg, C, Kraaij, R, Wagner, E, Ogris, Manfred
Published in Human gene therapy (01.12.2011)
Published in Human gene therapy (01.12.2011)
Get more information
Journal Article
296 Relevance of CYP17A1 Blockade in Clones of Castration-resistant Prostate Cancer
Kumagai, J, Erkens-Schulze, S, Dits, N.F.J, de Wit, R, van Weerden, W.M
Published in European journal of cancer (1990) (01.11.2012)
Published in European journal of cancer (1990) (01.11.2012)
Get full text
Journal Article
48 Lack of Clinical Efficacy of the Combination of Lenalidomide Plus Docetaxel is Predicted by the Lack of Effect in the Orthotopic PC346C Xenograft Model
van Weerden, W.M, Meulenbeld, H, Boer, A, Stuurman, D, Aghai, A, de Ridder, C.M.A, de Wit, R
Published in European journal of cancer (1990) (01.11.2012)
Published in European journal of cancer (1990) (01.11.2012)
Get full text
Journal Article
424 Taxane Efficacy is Positively Related to Intratumoral Concentrations in Patient-derived Prostate Cancer Xenografts
de Morrée, E.S, de Ridder, C.M, de Bruijn, P, Burger, H, Wiemer, E.A.C, Mathijssen, R.H, de Wit, R, van Weerden, W.M
Published in European journal of cancer (1990) (01.11.2012)
Published in European journal of cancer (1990) (01.11.2012)
Get full text
Journal Article
A0533 - Loss of glucocorticoid receptor expression in diagnostic biopsies of metastatic prostate cancer is associated with poor response to sequential docetaxel treatment
Moll, J.M., Mout, L., Kweldam, C.F., Wissing, M., de Morrée, E.M., Van Leenders, G.J.L.H., Jenster, G.W., Van Weerden, W.M.
Published in European urology (01.03.2024)
Published in European urology (01.03.2024)
Get full text
Journal Article
Loss of glucocorticoid receptor expression in diagnostic biopsies of metastatic prostate cancer is associated with poor response to sequential docetaxel treatment
Moll, J.M., Mout, L., Kweldam, C.F., Wissing, M., de Morrée, E.M., Van Leenders, G.J.L.H., Jenster, G.W., Van Weerden, W.M.
Published in European urology (01.03.2024)
Published in European urology (01.03.2024)
Get full text
Journal Article
A1149 - Patient-derived organoids represent intra- and interindividual heterogeneity in castration-resistant prostate cancer
Van Hemelryk, A., Tomljanovic, I., Erkens-Schulze, S., Teubel, W.J., De Ridder, C.M.A., Stuurman, D.C., Van Royen, M.E., Van Weerden, W.M.
Published in European urology (01.02.2023)
Published in European urology (01.02.2023)
Get full text
Journal Article
Patient-derived organoids represent intra- and interindividual heterogeneity in castration-resistant prostate cancer
Van Hemelryk, A., Tomljanovic, I., Erkens-Schulze, S., Teubel, W.J., De Ridder, C.M.A., Stuurman, D.C., Van Royen, M.E., Van Weerden, W.M.
Published in European urology (01.02.2023)
Published in European urology (01.02.2023)
Get full text
Journal Article
Standardization of viability assays and high-content live-cell imaging protocols for large-scale drug testing in prostate cancer PDX-derived organoids
Van Hemelryk, A., Erkens-Schulze, S., Lam, L., Stuurman, D., de Ridder, C.M.A., French, P.J., van Royen, M.E., van Weerden, W.M.
Published in European journal of cancer (1990) (01.10.2022)
Published in European journal of cancer (1990) (01.10.2022)
Get full text
Journal Article
Patient-derived xenografts and organoids recapitulate castration-resistant prostate cancer with sustained androgen receptor signaling
Van Hemelryk, A., Tomljanovic, I., Stuurman, D., de Ridder, C.M.A., Teubel, W.J., Erkens-Schulze, S., van de Werken, H.J.G., van Royen, M., Grudniewska, M., Jenster, G.W., van Weerden, W.M.
Published in European journal of cancer (1990) (01.10.2022)
Published in European journal of cancer (1990) (01.10.2022)
Get full text
Journal Article
Patient-derived preclinical models of castration resistant prostate cancer: Xenografts and PDX-derived organoids to recapitulate patients’ disease profiles
Van Hemelryk, A., Tomljanovic, I., De Ridder, C.M.A., Stuurman, D., Erkens-Schulze, S., Teubel, W.J., Verhoef, E.I., Van Leenders, G.J.L.H., Cangiano, M., Beumer, I.J., Van De Werken, H.J.G., Van Royen, M.E., Grudniewska, M., Van Weerden, W.M.
Published in European urology (01.06.2021)
Published in European urology (01.06.2021)
Get full text
Journal Article
Cabazitaxel efficacy is strongly enhanced by continued Androgen Receptor Targeted Agents (ARTA) in Castration-Resistant Prostate Cancer (CRPC)
Mout, L., Van Royen, M.E., De Ridder, C.M.A., Stuurman, D., Marques, R.B., De Geer, W.S., Van De Werken, H.J.G., Mathijssen, R.H.J., De Wit, R., Lolkema, M.P., Van Weerden, W.M.
Published in European urology (01.06.2021)
Published in European urology (01.06.2021)
Get full text
Journal Article
277 AR driven growth in CRPC depends predominantly on androgen precursors secreted by the adrenal gland
Moll, J.M, Teubel, W, Hofland, J, De Ridder, C.M.A, Taylor, A.E, Arlt, W, Greaser, R, Jenster, G, Van Weerden, W.M
Published in European urology supplements : official journal of the European Association of Urology (01.04.2015)
Published in European urology supplements : official journal of the European Association of Urology (01.04.2015)
Get full text
Journal Article
567 PET imaging of therapy-naïve primary prostate cancer patients using the GRPr-targeting ligand Sarabesin 3
Bakker, I.L, Fröberg, A.C, Busstra, M.B, Van Leenders, G.J.L.H, De Blois, E, Schoots, I, Veenland, J, Maina, T, Van Weerden, W.M, Nock, B.A, De Jong, M
Published in European urology supplements : official journal of the European Association of Urology (01.03.2016)
Published in European urology supplements : official journal of the European Association of Urology (01.03.2016)
Get full text
Journal Article
931 Novel nanobody targeting prostate-specific membrane antigen: A promising tracer for imaging of prostate cancer
Chatalic, K, Veldhoven-Zweistra, J, De Ridder, M.A, Bolkestein, M, De Blois, E, Van Duijn, M.M, Koning, G, Boerman, O.C, De Jong, M, Van Weerden, W.M
Published in European urology supplements : official journal of the European Association of Urology (01.04.2015)
Published in European urology supplements : official journal of the European Association of Urology (01.04.2015)
Get full text
Journal Article
824 Abiraterone is able to block AR activation induced by accumulating levels of precursor hormones resulting from CYP17A1 inhibition
Moll, J.M, Van Soest, R.J, Kumagai, J, Graeser, R, Hickson, I, Jenster, G.W, Van Weerden, W.M
Published in European urology supplements : official journal of the European Association of Urology (01.03.2013)
Published in European urology supplements : official journal of the European Association of Urology (01.03.2013)
Get full text
Journal Article
Peptide receptor imaging of prostate cancer with radiolabelled bombesin analogues
Schroeder, R.P.J., Weerden, W.M. van, Bangma, C., Krenning, E.P., Jong, M. de
Published in Methods (San Diego, Calif.) (01.06.2009)
Published in Methods (San Diego, Calif.) (01.06.2009)
Get full text
Journal Article
425 ERG immunohistochemistry is not predictive for PSA recurrence, local recurrence or overall survival after radical prostatectomy for prostate cancer
Hoogland, A.M, Jenster, G, Van Weerden, W.M, Trapman, J, Van Der Kwast, T, Roobol, M.J, Schröder, F.H, Wildhagen, M.F, Van Leenders, G.J.L.H
Published in European urology supplements : official journal of the European Association of Urology (01.02.2012)
Published in European urology supplements : official journal of the European Association of Urology (01.02.2012)
Get full text
Journal Article
835 INTRATUMORAL CONVERSION OF ADRENAL ANDROGENS IS MORE IMPORTANT THAN DE NOVO INTRATUMORAL STEROID SYNTHESIS IN PROSTATE CANCER
Kumagai, J, Hofland, J, Erkens-Schulze, S, Dits, N.F.J, Jenster, G, Bangma, C.H, Homma, Y, De Jong, F.H, Van Weerden, W.M
Published in European urology supplements : official journal of the European Association of Urology (2011)
Published in European urology supplements : official journal of the European Association of Urology (2011)
Get full text
Journal Article